Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
Authors:
- Inge StegemanISInge Stegeman
- Thomas R de WijkersloothTWThomas R de Wijkerslooth
- Rosalie C Mallant-HentRMRosalie C Mallant-Hent
- Karin de GrootKGKarin de Groot
- An K StroobantsASAn K Stroobants
- Paul FockensPFPaul Fockens
- Marco MundtMMMarco Mundt
- Patrick Mm BossuytPBPatrick Mm Bossuyt
- Evelien DekkerEDEvelien Dekker
Open Access
- 19 June 2012
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 12 (1) , 73
Abstract
Colorectal cancer (CRC) is the most common cancer in Europe with a mortality rate of almost 50%. The prognosis of patients is largely determined by the clinical and pathological stage at the time of diagnosis. Population screening has been shown to reduce CRC-related mortality rate. Most screening programs worldwide rely on fecal immunochemical testing (FIT). The effectiveness of a FIT screening program is not only influenced by initial participation rate, but also by program adherence during consecutive screening rounds. We aim to evaluate the participation rate in and yield of a third CRC screening round using FIT. Four years after the first screening round and two years after the second round, a total number of approximately 11,000 average risk individuals (50 to 75 years of age) will be invited to participate in a third round of FIT-based CRC screening. We will select individuals in the same target area as in the previous screening rounds, using the electronic database of the regional municipal administration registrations. We will invite all FIT-negatives and all non-participants in previous screening rounds, as well as eligible first time invitees who have moved into the area or have become 50 years of age. FITs will be analyzed in the special technique laboratory of the Academic Medical Center of the University of Amsterdam. All FIT-positives will be invited for a consultation at the outpatient clinic. In the absence of contra-indications, a colonoscopy will follow at the Academic Medical Center or at the Flevohospital. The primary outcome measures are the participation rate, defined as the proportion of invitees that return a FIT in this third round of FIT-screening, and the diagnostic yield of the program. This study will provide precise data on the participation in later FIT screening rounds. This enables to estimate the effectiveness of CRC screening programs that rely on repeated FIT- screening, such as the one that will be implemented in the Netherlands in 2013.Keywords
This publication has 16 references indexed in Scilit:
- Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialThe Lancet, 2010
- Estimates of cancer incidence and mortality in Europe in 2008European Journal of Cancer, 2010
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An UpdateAmerican Journal of Gastroenterology, 2008
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- Quality indicators for colonoscopyGastrointestinal Endoscopy, 2006
- [Revised CBO guideline 'Follow-up after polypectomy'].2001
- The Vienna classification of gastrointestinal epithelial neoplasiaGut, 2000
- Prevention of Colorectal Cancer by Colonoscopic PolypectomyNew England Journal of Medicine, 1993
- RANDOMISED, CONTROLLED TRIAL OF FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCERThe Lancet, 1989
- [Principles and practice of mass screening for disease].1968